Atlas Trials

Study of Longitudinal Plasma PD-L1 Testing With Immunotherapy in Lung Cancer

Clinical trial NCT06849518 · RECRUITING

Trial details

NCT number
NCT06849518
Sponsor
Ballad Health
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Lung Cancer (NSCLC)
Start date
2025-02-11
Primary completion
2026-03-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.